Hemoglobin A1c level is a prognostic factor for locoregional recurrence in stage III non‐small cell lung cancer patients treated with radiotherapy
Abstract Background The level of hemoglobin A1c (HbA1c) might be associated with the severity of tumor hypoxia in patients with cancer. Here, we evaluated the association between the level of HbA1c and survival outcome in stage III non‐small cell lung cancer patients treated with radical radiotherap...
Saved in:
Main Authors: | Moonkyoo Kong, Yu Jin Lim |
---|---|
Format: | article |
Language: | EN |
Published: |
Wiley
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f5c9b5ee6000452d9e939c41d589bf5f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes in pulmonary function tests in breast carcinoma patients treated with locoregional post-mastectomy radiotherapy: results of a pilot study
by: AlSaeed EF, et al.
Published: (2017) -
Factors associated with locoregional recurrence in penile cancer: a case-control study
by: Aldo Zárate-González, et al.
Published: (2021) -
Radiotherapy for Recurrent Keloid: A Case Report
by: Christina Hari Nawangsih Prihharsanti, et al.
Published: (2020) -
Prognostic implication of PD‐L1 polymorphisms in non‐small cell lung cancer treated with radiotherapy
by: Min Kyu Kang, et al.
Published: (2021) -
Effect of statins on breast cancer recurrence and mortality: a review
by: Van Wyhe RD, et al.
Published: (2017)